期刊
MICROMACHINES
卷 12, 期 10, 页码 -出版社
MDPI
DOI: 10.3390/mi12101171
关键词
SPCE biosensor; COVID-19; SARS-CoV-2
类别
资金
- MOST [110-2637-E-027-003]
- [NTUT-MMH-109-03]
This study aims to develop a biosensor that meets the criteria for point-of-care testing, with characteristics of adaptability, sensitivity, specificity, and user-friendliness. The research focuses on the sensitivity and modifiability of the biosensor, with the goal of providing diagnostic tools for the current pandemic and establishing an instant testing platform for future epidemics.
Due to the severe acute respiratory syndrome coronavirus (SARS-CoV-2, also called coronavirus disease 2019 (COVID-19)) pandemic starting in early 2020, all social activities ceased in order to combat its high transmission rate. Since vaccination combats one aspect for halting the spread of the virus, the biosensor community has looked at another aspect of reducing the burden of the COVID-19 pandemic on society by developing biosensors that incorporate point-of-care (POC) testing and the rapid identification of those affected in order to deploy appropriate measures. In this study, we aim first to propose a screen-printed carbon electrode (SPCE)-based electrochemical biosensor that meets the ASSURED criteria (i.e., affordable, sensitive, specific, user-friendly, rapid, equipment-free, and deliverable) for POC testing, but more importantly, we describe the novelty of our biosensor's modifiability that uses custom dual probes made from target nucleic acid sequences. Additionally, regarding the sensitivity of the biosensor, the lowest sample concentration was 10 pM (p = 0.0257) without amplification, which might challenge the traditional technique of reverse transcriptase-polymerase chain reaction (RT-PCR). The purpose of this study is to develop a means of diagnostics for the current pandemic as well as to provide an established POC platform for future epidemics.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据